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This paper describes afully-automated system (AUTO DISS(R))
for the determination ofactive ingredient release ofsolid oral dosage
forms according to the paddle method of the US Pharmacopoeia
USP) and European Pharmacopoeia.
Twenty batches can be tested continuou.sly, with the six individuals
(tablets, capsules etc.) of one batch being examined synchronous.
The components of the AUTO DISS(R) system are presented and
the operating steps of automatic filling with dissolution medium,
dropping in of tablets, sampling and cleaning of vessels are
described. Suitabilityfor testing controlled-release drugs by means
ofautomated buyffer changefrom simulated gastricfluid to simulated
intestinal fluid according to USP is also demonstrated. On-line
determination of active ingredient concentration, as well as
evaluation and documentation ofmeasured values, is possible using
an integrated automatic sampler in combination with various
measuring instruments.
The AUTO DISS(R) system is shown to be both rugged and accurate.
Introduction
Dissolution testing of solid oral dosage forms plays an
important part in:
(1) The development of new products, especially for
optimizing the bioavailability of a drug substance.
(2) Stability testing, i.e. to detect changes in drug release
as a result of different storage conditions.
(3) Quality control testing, i.e. to establish lot-to-lot
equivalence of formulations.
The most widely used dissolution method is the paddle
method, proposed by Levy and Hayes in 1960 [1] and
modifed by Poole [2]. This test is an essential item in
almost all pharmacopoeias. Data for registration at the
CTA (Clinical Trial Application) and NDA (New Drug
Application) stage must be included in the submitted
documentation.
As the manual procedure ofdissolution testing is expensive
and time-consuming, researchers began proposing ways
of automating the sampling and determination of the
dissolved drug soon after the introduction of dissolution
testing [3-9]. Sampling techniques are now highly
advanced and complete installations are offered by
vendors. These approaches to automating dissolution have
reduced the time required for the test. The scope of
automation, however, is restricted to testing a single batch.
A fully automated system capable of analysing more than
one batch must perform additional activities such as
sampling, dropping of tablets into vessels, draining of
dissolution medium, cleaning and drying of vessels
mechanically.
Dissolution testing can be automated using laboratory
robots [10-12]. These systems are now sophisticated
enough to execute more complicated operational steps of
the kind required in dissolution testing.
One serious disadvantage ofrobotic automation, however,
is that all working steps have to be carried out sequentially,
resulting in long processing times. Dissolution profiles with
short sampling intervals are especially problematic.
Moreover, because of their limited flexibility robotic
systems are frequently ill-suited to processing smaller series
of test samples involving a frequent change of method.
The present paper describes a more advanced system
[13-15], it differs from laboratory robotic systems in that
it can carry out all operating steps synchronously. The
apparatus (AUTO DISS (R), Manufacturer: Pharma Test,
Apparatebau GmbH Siemens Strasse 5, D63512 Hainburg,
Germany) is also suitable for fully automated testing of
sustained-release dosage forms. This requires mechanic-
ally implemented change of buffer from simulated gastric
fluid to simulated intestinal fluid according to USP.
Concept
In drug release testing by the paddle method, the
following basic operations can be combined into a single
cycle:
(1) Filling of vessels with dissolution medium.
(2) Heating of medium to required temperature.
(3) Dropping of dosage forms into vessels.
(4) Adjustment of paddle speed.
(5) Sampling at predetermined intervals and transfer of
solution to analytical instruments via autosampler.
(6) Change of dissolution medium from gastric fluid to
intestinal fluid for sustained-release dosage forms by
adding buffer solutions.
(7) Draining, rinsing and drying of dissolution vessels.
Upon completion of each separation step, the next cycle
starts automatically in accordance with the preselected
program.
Data collection and reduction, statistical calculation,
report generation and presentation of data can be
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the sampler to the analytical instruments in on-line
operation.
Figure 1. The AUTO DISS system with dissolution tester,
sample magazine,, automatic filling system and draining system.
implemented and a printout obtained via the PC-based
controller after the analytical determination. Method and







system comprises the following elements (see figure ):
Paddle apparatus with six vessels for tests and two
vessels for blank and reference standard. The vessels
and paddles are modified to allow draining of
medium, rinsing and drying to be carried out
automatically.
Magazines for each vessel (under nitrogen) storing
tablets or capsules for up to 20 batches.
An automatic system equipped with syringes and
valves for filling the vessels with dissolution medium,
changing the pH of the medium (important for
sustained-release dosage forms) and transferring the
samples to an autosampler.
A Gilson 232/401 (Gilson France, Villiers le Bel)
autosampler for 360 samples, equipped with two
Rheodyne valves for transferring test and standard
solutions to HPLC, FIA, spectrophotometric or other
instruments.
Containers for storing dissolution medium and buffer
solutions.
A microprocessor (MS DOS, IBM compatible) to
control the system and document the test parameters.
Standard software, for entering and storing methods
and data for evaluation and archiving. HPLC- and
UV-software for transferring sample solutions from
Construction .of vessel and paddle (figure 2)
The dimensions of the vessel and paddle correspond
precisely to those specified in the USP XXII.
A valve assembly consisting of the following parts is
flange-mounted on the base of the dissolution vessel (1):
a stainless steel screw thread (3) joined to the vessel and
the screw-on valve assembly (4).
Permanently connected to part (4) is the guide bush (6)
and (8) containing the freely movable Teflon plug (2)
and steel spring (7). Also mounted on part (4) is the olive
(5) as connector branch for a drain tube.
The stirrer consists of the paddle (11) which is welded to
the metal tube (10). The paddle shaft (9) is connected to
the channels (12) in the paddle.
Figure 2 also shows the upper end of the paddle shaft (9)
and (10), which projects above the drive unit housing of
the drug release apparatus (18). The metal housing (16)
encases the paddle shaft and is fixed with the lock nut
(17) and the paired seal rings (15), the upper shaft seal
ring being connected to the screw fitting (14). The
connecting branch (13) for water and compressed air
supply is joined directly to the screw fitting (14).
Sample magazine
The sample magazine is installed above the front part of
the drug release apparatus. This magazine consists of a
stainless-steel plate with a 15 mm diameter hole for each
dissolution vessel. The plate is provided with circular,
rotatable Teflon disks with a diameter of 14 cm and a
thickness of 16 mm.
Located around the periphery of each disk are 20 holes
each with an internal diameter of 14 mm; these holes serve
as containers for the dosage forms under test. With the
aid of a motor, all six disks can be rotated synchronously
so that the solid dosage form drops into the release medium
when the hole in the disk is aligned directly above the
hole in the plate. The sample magazine is protected
against external influences by an acrylic glass hood. The
magazine can also be aerated with air or nitrogen to
prevent after-hardening of tablets or adhesion of soft
gelatin capsules to the container wall due to steam from
the heating bath during prolonged residence times.
Dispenser station
The dispenser station consists of eight syringe units which
supply the sample vessels and the vessels for blank or
reference standard solutions. The dilutors (50 ml volume),
which are driven by the same motor, are used to fill the
dissolution vessels with medium, withdraw samples and
transfer the solutions to the automatic sampler, and to
modify the pH of the dissolution medium when testing
controlled release drugs. Each dilutor is connected to an
eight-way valve. These valves allow media, such as buffer
solutions or various release solutions, to be transferred to
the vessels.















Figure 2. Cross-section of glass vessel and paddle construction.
(1) Dissolution vessel. (2) Plug. (3) Stainless steel screw thread.
(4) Valve assembly. (5) Olive. (6) auie bus. (7)Steel spring.
(8) Guide bush. (9) Tube cavity. (10) Metal tube.
(11) Paddle. (12) Channels. (13) Connecting branch for water
and compressed air. (14) Screw fitting. (15) Seal rings.
(16) Metal housing. (17)Lock nut. (18)Drive unit housing.
Autosampler
A Gilson 232/401 is preferred as autosampler, as it has a
maximum capacity of 360 samples; it can also be used
simultaneously as a sample injection system, as it has
rheodyne valves. With the aid of the Gilson dilutor the
collected test solutions can be transferred directly to the
measuring instruments, such as spectrophotometer, high-
performance liquid chromatograph or flow-injection
system.
Controller
The AUTO-DISS apparatus is controlled and monitored
by a microprocessor (MS DOS, IBM compatible).
Standard software is employed for entering and storing
methods and data for evaluation and documentation.
Software for on-line processing by means ofGilson 232/401
Figure 3. Operating steps within a cycle.
ur:he yes
end
with spectrophotometric or liquid chromatographic
evaluation is also available.
Operating procedure
The operating procedure for one cycle, in which all the
steps from filling the vessels with dissolution medium to
cleaning and drying of the vessels are controlled auto-
matically via a microcomputer, is shown in figure 3.
As many as 20 cycles can be processed automatically in
succession, with up to six individual tablets being tested
per cycle.
Before starting serial testing, parametrization is performed
via the dialogue program. The following variables are
established:
(1) Number ofcycles (maxN 20, i.e. 20 x 6 tablets).
(2) Volume of dissolution medium (min 500 ml/max
1000 ml).
(3) Temperature of dissolution medium (rain RT/max
45C).
(4) Paddle speed (min 25 r.p.m./max 250 r.p.m.).
(5) Test solutions: volume (min ml/max 50ml),
number and time of samplings.
(6) Rinsing times and rinsing volumes for sanple tubes.
(7) Buffer solutions for pH change: volume dosing
depending on type of buffer and required pH.
(8) Sample coding in autosampler system for identi-
fication for measurement and documentation of
samples.
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(9) Cleaning steps for vessels and paddles.
(10) Rinsing of syringe station and all tubes.
After establishing the parameters, the dissolution vessels
are filled simultaneously with dissolution medium from a
storage vessel by means of a syringe system. After a
constant temperature has been reached, the micro-
computer activates the drive motor for the sample
magazine. When the motor has moved the sample
magazine one step hole onward, it is switched off by the
microcomputer. The samples to be tested fall simul-
taneously through specially positioned holes into the
individual dissolution vessels. The paddles are then set in
motion. The solutions to be measured are transferred
according to a preselected program via the dispenser
station directly to a Gilson 232 autosampler, or, option-
ally, to the multicell transport system of a spectrophoto-
meter. For sustained-release preparations, the dispenser
station also changes the pH buffer from simulated gastric
fluid in all dissolution vessels simultaneously. In accord-
ance with Method A of USP XXII, 250 ml quantities of
buffer solution are pumped from storage containers
through integrated valve circuits directly into the receiv-
ing vessels each containing 750 ml 0"IN hydrochloric acid.
Automatic drainage of the dissolution medium, cleaning
and drying of t’he vessels and .paddles are described in
detail in [13, 14]. After this cleaning step, the first cycle
is completed and the dissolution vessels can be refilled
with dissolution medium.
Suitability and validation oftheAUTO DISS system
To prove the suitability of the dissolution tester, a series
ofexperiments was performed. In the following the results
and experimental procedure according to USP XXII for
dissolution testing of calibrator tablets are presented;
buffer change experiments are then described which prove
the suitability of the AUTO DISS system for testing the
release of sustained-release dosage forms; and, finally, the
robustness of the system is demonstrated by a 700 hour
continuous test.
Dissolulion @prednisone and salicylic acid tablets
Prednisone tablets
Test preparation: prednisone tablets 50 mg, lot J.
Test apparatus" AUTO DISS system, Pharma Test
GmbH, Hainburg, Germany (apparatus II, Ph. Eur. V
5.4, apparatus I, USP XXII) with Gilson 232 auto-
sampler system.
Test and measuring conditions" Dissolution medium:
900 ml water; paddle speed: 50 r.p.m, and 100 r.p.m.,
sampling interval" 30 min; sample volume: 5 ml; tempera-
ture: 37C + 0.5C; measurement method’ flow injection
analysis [14] tbllowed by UV detection (242 nm).
Evaluation: The dissolved active ingredient concentra-
tions were determined against prednisone USP XXII
retrence standard.
Specifications" 50 r.p.m." 46-59, 100 r.p.m." 58-69%.
Resull: prednisone in (see table 1).
Table 1. Results of dissolution ofprednisone and salicylic acid.
Prednisone (%) Salicylic acid (%)
Tablet No. 50 r.p.m. 100 r.p.m. 50 r.p.m. 100 r.p.m.
56"0 67"9 15"7 22"6
2 56"9 67"9 20’ 22"8
3 56"8 66"9 17"7 22"4
4 56"9 67"7 16"3 21"1
5 57"7 69"0 17-9 21 ’6
6 56"6 66"8 16"7 22’6
Xm 56"8 67"9 17"4 22"2
0"5 0"8 1"6 0"7
RSD (%) 1.0 1-5 9.0 3"0
Salicylic acid tablets
Test preparation: salicylic acid tablets 300 mg, lot H.
Test apparatus" AUTO DISS system, with Gilson 232
autosampler system.
Test and measuring conditions: Dissolution medium"
900 ml 0"05 mol/1 phosphate buffer pH 7"4; paddle speed"
50 and 100 r.p.m., sampling interval: 30 min; sample
volume: 5 ml; temperature: 37C _+ 0"5C; measurement
method" flow injection analysis followed by UV detection
(296 nm) [ 14].
Evaluation" The dissolved active ingredient concentra-
tions were determined against salicyclic acid USP XXII
reference standard.
Specifications: 50 r.p.m." 13-23%, 100 r.p.m." 18-31%.
Result: salicyclic acid in % (see table 1).
Results: The active ingredient release specifications are
complied with by the prednisone and the salicylic acid
tablets, since all the individual values are within the
specified tolerance limits. It is noticeable that the standard
deviations within the test series show comparatively low
values. The reproducibility of the tablet release profile is
therefore good, and the dissolution vessels are very
homogeneous in relation to each other.
pH change
In vitro simulation of the conditions in the gastrointestinal
tract, especially in testing of sustained-release or enteric
dosage forms, requires a pH change from simulated gastric
fluid to simulated intestinal fluid. These tests involving
buffer change are very time-consuming and should
therefore be automated. The AUTO .DISS system was
therefore designed to provide automated change ofbuffer,
for which the following criterion must be met.
The US Pharmacopoeia stipulates a pH of 6"8 with a
tolerance of __.0"05 pH units when changing the buffer
from simulated gastric fluid (0"1 mol/1 hydrochloric acid)
to simulated intestinal fluid with the aid of phosphate
buffer solutions. To ensure compliance with this narrow
tolerance, the AUTO DISS system incorporates a highly
precise dispenser station with additional switching valves
for solvents for all dissolution vessels.
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Table 2. Reproducibility of buffer changefrompH 1"0 topH 6"8.
pH
1st 2nd 3rd
Vessel No. determination determination determination
6"80 6"83 6"80
2 6"82 6"82 6"80
3 6"83 6’82 6"79
4 6"78 6"83 6"78
5 6"80 6"82 6"78
6 6"79 6"81 6"79
Xm 6"80 6"82 6"79
0"02 0"01 0"01
RSD () 0"3 0" 0"
Experimental procedure and determination ofprecision
A predetermined volume of 0"1 mol/1 hydrochloric acid
(750 ml) is transferred via the dispenser station to the
vessels. To change the pH, the valve units are switched
and 250 ml of 0"02 mol/1 trisodium phosphate solution is
drawn from a storage vessel and added to all the
dissolution vessels simultaneously via the piston syringes.
A rinsing cycle is then carried out to remove the excess
buffer solution from the system.
Table 2 demonstrates the good reproducibility of the
buffer change from simulated gastric fluid (pH 1) to
simulated intestinal fluid (pH 6"8). A tolerance of ___
0"05 pH
units is maintained in all tests.
Recording of a dissolution profile--theophylline sustained-release capsules
Test preparation: Theophylline sustained-release capsules
300 mg, lot 801 102. Manufacturer: Boehringer Ingelheim
KG.
Test apparatus: AUTO DISS system with Gilson 232
autosampler system.
Test and measuring conditions" Dissolution medium:
900 ml 0"1 mol/1 hydrochloric acid/phosphate buffer 6"8;
paddle speed" 150 r.p.m., sampling intervals 1, 2, 4,
6, 8, 10 h; sample volume: 5 ml.
Buffer change from pH to pH 6"8 is performed after h.
Temperature" 37 0"5C; measurement method UV
detection (270 nm).
Evaluation: Determination of the dissolved active ingred-
ient concentrations is performed against theophylline
reference substance. The concentrations of theophylline
calculated in the dissolution test are stated in /o in table 3.
Robustness of the AUTO DISS system
The AUTO DISS apparatus was subjected to a stress test
in which the system was kept in continuous operation for
about 700 hours. Analyses were performed both on
development products with a low active ingredient
content (pramipexole tablets 0"1 mg) and on licensed
products of the Lonarid series (tablets with 500mg
paracetamol, 0"5 mg dihydroergotamine and 10 mg
codeine phosphate). Altogether 526 batches and/or
stability samples were tested during the investigational
period (N 6; 3156 samples).
As well as checking the reproducibility of the products
(of known content uniformity), particular attention was
paid to assessing the mechanical robustness of the AUTO
DISS apparatus.
Comment
During the 700 hour long-term test, no mechanical
deficiencies were observed, except for a rapidly repaired
leak in one dilutor. All other mechanical moving parts,
such as media drain valves, eight-way valves, dispenser
unit and the Gilson 232/401 autosampler, worked
perfectly. Neither were there problems with the sintered
glass filters for the samples, problems of entrainment of
active ingredients in the cleaning operations or problems
of adsorption on tubing.
All the individual data recorded were within the specified
requirements. The reproducibility of the groups of
investigated products exhibited similar coefficients of
variation as the content uniformity of the corresponding
products. It can therefore be concluded that the entire
system operates reproducibly.
The positive general impression obtained for the AUTO
DISS apparatus allows the conclusion that the system is
extremely reliable and therefore suitable for use in the
development and quality-control areas.
Discussion
Manual testing of active ingredient release from oral
dosage forms using the paddle method is the most time-
Table 3. Results of dissolution of theophyllinefrom sustained-release capsules in % after 1, 2, 4, 6, 8, and 10 h.
Active ingredient concentration ()
Sampling intervals
(h) 2 3 4 5 6 Xm
RSD
23"0 20"0 16"5 23"5 18"0 21"5 20"4 2"8 13"6
2 37"5 32"8 29"4 36"8 30"8 34"8 33"7 3"3 9"7
4 60"3 53"6 48"9 59"0 52"9 56"3 55"2 4"2 7" 7
6 79"3 72"6 71"8 79"3 73"9 75"3 75"4 3"3 4"3
8 93"0 85"6 87"5 92"4 88"2 90"3 89"5 2"9 3"2
10 100"8 93"3 97"3 100"8 98"7 99"4 98"4 2"8 2"9
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consuming operation in the analytical characterization of
drugs. Filling, buffer change (for controlled-release
drugs), emptying and cleaning operations in particular
are mindless activities for laboratory staff. Automating
these operations results not only in more streamlined
performance ofdissolution testing but also in standardiza-
tion of techniques.
With the AUTO DISS system, as many as 20 determina-
tions can be carried out in a 24-hour rhythm. This
represents a considerable increase in capacity.
Combining the various analytical methods, for example
spectrophotometry (including diode array spectroscopy),
liquid chromatography and flow injection analysis with
the AUTO DISS system increases the flexibility of the
system. The requirement for laboratory staff is thereby
reduced and technicians are relieved of time-consuming
routine work.
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